V. ÖZKOCAMAN Et Al. , "Efficacy Of Plerixafor Plus Granulocyte Colony-Stimulating Factor (G-CSF) İn Patients With Multiple Myeloma And Lymphoma Who Have Had Mobilization Failure With At Least Two Regimens. A Retrospective Single-Center Study," 48th ANNUAL MEETİNG EBMT , Praha, Czech Republic, pp.47, 2022
ÖZKOCAMAN, V. Et Al. 2022. Efficacy Of Plerixafor Plus Granulocyte Colony-Stimulating Factor (G-CSF) İn Patients With Multiple Myeloma And Lymphoma Who Have Had Mobilization Failure With At Least Two Regimens. A Retrospective Single-Center Study. 48th ANNUAL MEETİNG EBMT , (Praha, Czech Republic), 47.
ÖZKOCAMAN, V., ÖZKALEMKAŞ, F., Pınar, İ. E., ERSAL, T., BULDU, M., & GÜRSOY, V., (2022). Efficacy Of Plerixafor Plus Granulocyte Colony-Stimulating Factor (G-CSF) İn Patients With Multiple Myeloma And Lymphoma Who Have Had Mobilization Failure With At Least Two Regimens. A Retrospective Single-Center Study . 48th ANNUAL MEETİNG EBMT (pp.47). Praha, Czech Republic
ÖZKOCAMAN, VİLDAN Et Al. "Efficacy Of Plerixafor Plus Granulocyte Colony-Stimulating Factor (G-CSF) İn Patients With Multiple Myeloma And Lymphoma Who Have Had Mobilization Failure With At Least Two Regimens. A Retrospective Single-Center Study," 48th ANNUAL MEETİNG EBMT, Praha, Czech Republic, 2022
ÖZKOCAMAN, VİLDAN Et Al. "Efficacy Of Plerixafor Plus Granulocyte Colony-Stimulating Factor (G-CSF) İn Patients With Multiple Myeloma And Lymphoma Who Have Had Mobilization Failure With At Least Two Regimens. A Retrospective Single-Center Study." 48th ANNUAL MEETİNG EBMT , Praha, Czech Republic, pp.47, 2022
ÖZKOCAMAN, V. Et Al. (2022) . "Efficacy Of Plerixafor Plus Granulocyte Colony-Stimulating Factor (G-CSF) İn Patients With Multiple Myeloma And Lymphoma Who Have Had Mobilization Failure With At Least Two Regimens. A Retrospective Single-Center Study." 48th ANNUAL MEETİNG EBMT , Praha, Czech Republic, p.47.
@conferencepaper{conferencepaper, author={VİLDAN ÖZKOCAMAN Et Al. }, title={Efficacy Of Plerixafor Plus Granulocyte Colony-Stimulating Factor (G-CSF) İn Patients With Multiple Myeloma And Lymphoma Who Have Had Mobilization Failure With At Least Two Regimens. A Retrospective Single-Center Study}, congress name={48th ANNUAL MEETİNG EBMT}, city={Praha}, country={Czech Republic}, year={2022}, pages={47} }